| abstract |
The present invention relates to novel peptide compounds that are effective in modulating one or more melanocortin receptor types, the use of the compounds in therapy, and therapies comprising administering the compounds to patients in need thereof Methods, the use of the compounds in the manufacture of a medicament. The compounds of the invention are of particular interest for the treatment of obesity, as well as for the treatment of various diseases or conditions associated with obesity. [Selection figure] None |